Triflute T Tablet
Triflute T Tablet contains Trifluoperazine 5mg, a well-established typical antipsychotic, and Trihexyphenidyl 2mg, an anticholinergic agent used to prevent movement-related side effects. This dual-action formulation is commonly prescribed for the treatment of schizophrenia, psychosis, behavioral disorders, and agitation caused by neurological conditions.
Trifluoperazine works by regulating dopamine activity in the brain to control psychotic symptoms such as hallucinations, delusions, anxiety, and mood instability. Trihexyphenidyl helps prevent extrapyramidal symptoms (EPS), rigidity, tremors, and restlessness that may occur due to antipsychotic therapy.
This medicine belongs to the neuro-psychiatry and CNS therapeutic segment and is widely used in psychiatric hospitals, mental health clinics, rehabilitation centers, and neurology care establishments.
Due to its strong and recurring demand, Triflute T Tablet presents a valuable opportunity for PCD pharma franchise partners, wholesalers, institutional suppliers, and export markets. It is also available for private label manufacturing and bulk commercial supply with competitive business margins.
Common side effects may include dry mouth, constipation, blurred vision, dizziness, sleepiness, weight changes, restlessness, or low blood pressure. Rarely, it may cause tremors, difficulty urinating, or allergic reactions.
Triflute T Tablet is used for the management of schizophrenia, psychosis, anxiety disorders, and to control drug-induced extrapyramidal symptoms such as tremors, rigidity, drooling, and muscle stiffness. It helps improve mood, behavior, and daily functioning.
Avoid alcohol and activities requiring alertness, such as driving. Use cautiously in patients with heart disease, glaucoma, seizures, kidney or liver problems. Do not stop the medication abruptly without medical advice, as withdrawal symptoms may occur.
Store in a cool and dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.